KiSS1 metastasis suppressor gene product induces suppression of tyrosine kinase receptor signaling to Akt, tumor necrosis factor family ligand expression, and apoptosis

Molecular Pharmacology

Volumn 75, Issue 5, 2009, Pages 1074-1083

  Navenot, Jean Marc ^a,c   Fujii, Nobutaka ^b   Peiper, Stephen C ^a,c  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b KYOTO UNIVERSITY   (Japan)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; FAS LIGAND; G PROTEIN COUPLED RECEPTOR 54; INSULIN; KISSPEPTIN; KISSPEPTIN 10; METASTIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLSERINE; TUMOR NECROSIS FACTOR ALPHA; TYROSINE KINASE RECEPTOR;

APOPTOSIS; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; EPITHELIUM CELL; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LYMPHOID CELL LINE; METASTASIS INHIBITION; MITOCHONDRIAL MEMBRANE POTENTIAL; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL; WESTERN BLOTTING;

APOPTOSIS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; JURKAT CELLS; OLIGOPEPTIDES; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, INSULIN; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; TUMOR SUPPRESSOR PROTEINS;

EID: 66049134289     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.108.054270     Document Type: Article

References (40)

1. Becker JA, Mirjolet JF, Bernard J, Burgeon E, Simons MJ, Vassart G, Parmentier M, and Libert F (2005) Activation of GPR54 promotes cell cycle arrest and apoptosis of human tumor cells through a specific transcriptional program not shared by other Gq-coupled receptors. Biochem Biophys Res Commun 326:677-686. (Pubitemid 39642778)
2. Carpenter CL and Cantley LC (1996) Phosphoinositide kinases. Curr Opin Cell Biol 8:153-158. (Pubitemid 26109087)
3. Dhar DK, Naora H, Kubota H, Maruyama R, Yoshimura H, Tonomoto Y, Tachibana M, Ono T, Otani H, and Nagasue N (2004) Downregulation of KiSS-1 expression is responsible for tumor invasion and worse prognosis in gastric carcinoma. Int J Cancer 111:868-872. (Pubitemid 39096235)
4. Dorsam RT and Gutkind JS (2007) G-protein-coupled receptors and cancer. Nat Rev Cancer 7:79-94. (Pubitemid 46164746)
5. Dumitru CD, Ceci JD, Tsatsanis C, Kontoyiannis D, Stamatakis K, Lin JH, Patriotis C, Jenkins NA, Copeland NG, Kollias G, et al. (2000) TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway. Cell 103:1071-1083. (Pubitemid 32040907)
6. Folli F, Kahn CR, Hansen H, Bouchie JL, and Feener EP (1997) Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin/angiotensin II crosstalk. J Clin Invest 100:2158-2169. (Pubitemid 27500137)
7. Goldberg SF, Miele ME, Hatta N, Takata M, Paquette-Straub C, Freedman LP, and Welch DR (2003) Melanoma metastasis suppression by chromosome 6: evidence for a pathway regulated by CRSP3 and TXNIP. Cancer Res 63:432-440. (Pubitemid 36152504)
8. Gupta GP and Massagué J (2006) Cancer metastasis: building a framework. Cell 127:679-695.
9. Häcker H and Karin M (2006) Regulation and function of IKK and IKK-related kinases. Sci STKE 2006:re13.
10. Hata K, Dhar DK, Watanabe Y, Nakai H, and Hoshiai H (2007) Expression of metastin and a G-protein-coupled receptor (AXOR12) in epithelial ovarian cancer. Eur J Cancer 43:1452-1459. (Pubitemid 46874063)
11. Hori A, Honda S, Asada M, Ohtaki T, Oda K, Watanabe T, Shintani Y, Yamada T, Suenaga M, Kitada C, et al. (2001) Metastin suppresses the motility and growth of CHO cells transfected with its receptor. Biochem Biophys Res Commun 286:958-963. (Pubitemid 32924865)
12. Ikeguchi M, Yamaguchi K, and Kaibara N (2004) Clinical significance of the loss of KiSS-1 and orphan G-protein-coupled receptor (hOT7T175) gene expression in esophageal squamous cell carcinoma. Clin Cancer Res 10:1379-1383. (Pubitemid 38365232)
13. Jiang Y, Berk M, Singh LS, Tan H, Yin L, Powell CT, and Xu Y (2005) KiSS1 suppresses metastasis in human ovarian cancer via inhibition of protein kinase C alpha. Clin Exp Metastasis 22:369-376. (Pubitemid 41609296)
14. Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, Cordón-Cardo C, Guise TA, and Massagué J (2003) A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3:537-549. (Pubitemid 36808649)
15. Kolch W (2005) Coordinating ERK/MAPK signalling through scaffolds and inhibitors. Nat Rev Mol Cell Biol 6:827-837. (Pubitemid 41568732)
16. Kotani M, Detheux M, Vandenbogaerde A, Communi D, Vanderwinden JM, Le Poul E, Brézillon S, Tyldesley R, Suarez-Huerta N, Vandeput F, et al. (2001) The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54. J Biol Chem 276:34631-34636. (Pubitemid 37384458)
17. Lee JH, Miele ME, Hicks DJ, Phillips KK, Trent JM, Weissman BE, and Welch DR (1996) KiSS-1, a novel human malignant melanoma metastasis-suppressor gene. J Natl Cancer Inst 88:1731-1737. (Pubitemid 26405010)
18. Lee JH and Welch DR (1997) Suppression of metastasis in human breast carcinoma MDA-MB-435 cells after transfection with the metastasis suppressor gene, KiSS-1. Cancer Res 57:2384-2387. (Pubitemid 27255895)
19. Luttrell LM, Roudabush FL, Choy EW, Miller WE, Field ME, Pierce KL, and Lefkowitz RJ (2001) Activation and targeting of extracellular signal-regulated kinases by β-arrestin scaffolds. Proc Natl Acad Sci U S A 98:2449-2454. (Pubitemid 32209502)
20. Manning BD and Cantley LC (2007) AKT/PKB signaling: navigating downstream. Cell 129:1261-1274. (Pubitemid 46962095)
21. Martins CM, Fernandes BF, Antecka E, Di Cesare S, Mansure JJ, Marshall JC, and Burnier MN Jr (2008) Expression of the metastasis suppressor gene KISS1 in uveal melanoma. Eye 22:707-711.
22. Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD, Viale A, Olshen AB, Gerald WL, and Massagué J (2005) Genes that mediate breast cancer metastasis to lung. Nature 436:518-524. (Pubitemid 41112921)
23. Mitchell DC, Stafford LJ, Li D, Bar-Eli M, and Liu M (2007) Transcriptional regulation of KiSS-1 gene expression in metastatic melanoma by specificity protein-1 and its coactivator DRIP-130. Oncogene 26:1739-1747. (Pubitemid 46426193)
24. Muir AI, Chamberlain L, Elshourbagy NA, Michalovich D, Moore DJ, Calamari A, Szekeres PG, Sarau HM, Chambers JK, Murdock P, et al. (2001) AXOR12, a novel human G protein-coupled receptor, activated by the peptide KiSS-1. J Biol Chem 276:28969-28975. (Pubitemid 37451980)
25. Nash KT, Phadke PA, Navenot JM, Hurst DR, Accavitti-Loper MA, Sztul E, Vaidya KS, Frost AR, Kappes JC, Peiper SC, et al. (2007) Requirement of KISS1 secretion for multiple organ metastasis suppression and maintenance of tumor dormancy. J Natl Cancer Inst 99:309-321. (Pubitemid 47078727)
26. Navenot JM, Wang Z, Chopin M, Fujii N, and Peiper SC (2005) Kisspeptin-10-induced signaling of GPR54 negatively regulates chemotactic responses mediated by CXCR4: a potential mechanism for the metastasis suppressor activity of kisspeptins. Cancer Res 65:10450-10456. (Pubitemid 41743739)
27. Ohtaki T, Shintani Y, Honda S, Matsumoto H, Hori A, Kanehashi K, Terao Y, Kumano S, Takatsu Y, Masuda Y, et al. (2001) Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor. Nature 411:613-617. (Pubitemid 32531412)
28. Prentice LM, Klausen C, Kalloger S, Köbel M, McKinney S, Santos JL, Kenney C, Mehl E, Gilks CB, Leung P, et al. (2007) Kisspeptin and GPR54 immunoreactivity in a cohort of 518 patients defines favourable prognosis and clear cell subtype in ovarian carcinoma. BMC Med 5:33.
29. Roberts PJ and Der CJ (2007) Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene 26:3291-3310.
30. Sanchez-Carbayo M, Capodieci P, and Cordon-Cardo C (2003) Tumor suppressor role of KiSS-1 in bladder cancer: loss of KiSS-1 expression is associated with bladder cancer progression and clinical outcome. Am J Pathol 162:609-617. (Pubitemid 36267867)
31. Sebolt-Leopold JS (2008) Advances in the Development of Cancer Therapeutics Directed against the RAS-Mitogen-Activated Protein Kinase Pathway. Clin Cancer Res 14:3651-3656.
32. Seino K, Kayagaki N, Okumura K, and Yagita H (1997) Antitumor effect of locally produced CD95 ligand. Nat Med 3:165-170. (Pubitemid 27064700)
33. Shimizu M, Fontana A, Takeda Y, Yagita H, Yoshimoto T, and Matsuzawa A (1999) Induction of antitumor immunity with Fas/APO-1 ligand (CD95L)-transfected neuroblastoma neuro-2a cells. J Immunol 162:7350-7357. (Pubitemid 29277711)
34. Shirasaki F, Takata M, Hatta N, and Takehara K (2001) Loss of expression of the metastasis suppressor gene KiSS1 during melanoma progression and its association with LOH of chromosome 6q16.3-q23. Cancer Res 61:7422-7425. (Pubitemid 32995028)
35. Skinner SJ, Deleault KM, Fecteau R, and Brooks SA (2008) Extracellular signal-regulated kinase regulation of tumor necrosis factor-α mRNA nucleocytoplasmic transport requires TAP-NxT1 binding and the AU-rich element. J Biol Chem 283:3191-3199.
36. Stafford LJ, Vaidya KS, and Welch DR (2008) Metastasis suppressors genes in cancer. Int J Biochem Cell Biol 40:874-891.
37. van den Brink MR, Kapeller R, Pratt JC, Chang JH, and Burakoff SJ (1999) The extracellular signal-regulated kinase pathway is required for activation-induced cell death of T cells. J Biol Chem 274:11178-11185. (Pubitemid 129528328)
38. Welch DR, Chen P, Miele ME, McGary CT, Bower JM, Stanbridge EJ, and Weissman BE (1994) Microcell-mediated transfer of chromosome 6 into metastatic human C8161 melanoma cells suppresses metastasis but does not inhibit tumorigenicity. Oncogene 9:255-262. (Pubitemid 24020957)
39. West A, Vojta PJ, Welch DR, and Weissman BE (1998) Chromosome localization and genomic structure of the KiSS-1 metastasis suppressor gene (KISS1). Genomics 54:145-148. (Pubitemid 28536204)
40. Zhu L, Yu X, Akatsuka Y, Cooper JA, and Anasetti C (1999) Role of mitogen-activated protein kinases in activation-induced apoptosis of T cells. Immunology 97:26-35. (Pubitemid 29217257)